Debiopharm Group (Canada)

Recent papers from Debiopharm Group (Canada)

1. BW-00112 targeting ANGPTL3 results in prolonged reductions in plasma triglycerides, LDL-C, and remnant-C in Chinese healthy subjectsEuropean Heart Journal · 2025
2. Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory PlantDefensinACS Pharmacology & Translational Science · 2020
3. Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the BloodBiological and Pharmaceutical Bulletin · 2017
4. Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATPGut · 2015